ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Fasenra 30 mg /1 ml, Injektionslösung in einer Fertigspritze - 
66582001 AstraZeneca AG
Fasenra 30 mg /1 ml, Injektionslösung in einer Fertigspritze08.06.2018
  08.06.2018
Benralizumab (R03DX10) 
WHO-DDD 
03.04.50. 
03.04.50. 
B  
Yes 
IPCI
2319.39Yes
    
10 %2538.90
7680665820019Biotechnologika
7452343 
Composition
benralizumabum 30 mg, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Packungsbestandteile
Injection solution in prefilled syringe 
  
 
Active AgentDose
Benralizumabum30 mg/ml
BAG: Active AgentDose
Benralizumabum30 mg
 
Inactive agents
Histidin Hydrochloride Monohydrate
Histidine
Polysorbatum 20
Trehalosum Dihydricum
 
Source
Data was imported : 06.11.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home